Prenetics

Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment in Taiwan, Hong Kong, the United Kingdom, and internationally. It operates through two segments: Prevention and Diagnostics. The company offers CircleDNA, a consumer genetic testing product to offer comprehensive DNA test. It also provides Insighta develops and commercializes multi-cancer early detection technology named Fragma. In addition, the company, through acquisition of ACT Genomics, which is involved in genomic profiling of panels through ACTOnco, ACT HRD, ACTFusion, and ACTDrug. Further, the company offers ACTLiquid Pro, an NGS-based liquid biopsy assay for pan-solid tumors; ACTMonitor which provides realtime monitoring of drug resistance, treatment response, and cancer recurrence; and ACT Risk which manages the cancer risk. Prenetics Global Limited is based in Quarry Bay, Hong Kong.

Prenetics, established in 2009 and headquartered in Asia., specializes in Seed investments across Metaverse, Apps, Video Games, Blockchain, Casual Games, Developer Platform, Web3, Gaming, Artificial Intelligence (AI), Food and Beverage. Their recent investments include Animoca Brands, Brinc, Protocol Labs, Olivex, Zilliqa Capital. The highest investment round they participated in was $42.0M. Among their most notable exits are Animoca Brands and Brinc. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.